J J Bechtel1, T L Petty, G Saccomanno. 1. Department of Internal Medicine and Pulmonology Diseases, St. Mary's Hospital and Medical Center, Grand Junction, CO, USA.
Abstract
BACKGROUND: A cohort of 51 consecutive patients with roentgenographically occult lung cancer, identified by sputum cytology and confirmed by bronchoscopy was reported previously. METHODS: All patients have now been followed beyond 5 years and the causes of death ascertained. RESULTS: The actual 5-year survival of 27 patients who were resected for cure was 74% including death for all causes. The 5-year survival of all patients who received either surgery or radiation in an attempt to cure was 54.3%. Twelve secondary cancers were found by sputum cytology; eight of these patients have died. CONCLUSIONS: Sputum cytology can be useful in the identification of early stage lung cancer in patients at high-risk where the chances of cure are favorable.
BACKGROUND: A cohort of 51 consecutive patients with roentgenographically occult lung cancer, identified by sputum cytology and confirmed by bronchoscopy was reported previously. METHODS: All patients have now been followed beyond 5 years and the causes of death ascertained. RESULTS: The actual 5-year survival of 27 patients who were resected for cure was 74% including death for all causes. The 5-year survival of all patients who received either surgery or radiation in an attempt to cure was 54.3%. Twelve secondary cancers were found by sputum cytology; eight of these patients have died. CONCLUSIONS: Sputum cytology can be useful in the identification of early stage lung cancer in patients at high-risk where the chances of cure are favorable.
Authors: Eric Edell; Stephen Lam; Harvey Pass; York E Miller; Thomas Sutedja; Timothy Kennedy; Gregory Loewen; Robert L Keith; Adi Gazdar Journal: J Thorac Oncol Date: 2009-01 Impact factor: 15.609
Authors: D F Tan; J A Huberman; A Hyland; G M Loewen; J S Brooks; A F Beck; I T Todorov; G Bepler Journal: BMC Cancer Date: 2001-06-25 Impact factor: 4.430